GALAXY
Gut-and-Liver Axis in Alcoholic Liver Fibrosis
What is GALAXY?
The vision of GALAXY is to optimize personalized healthcare for patients with liver disease,
by stratifying individuals who would benefit from targeted healthcare efforts versus those who would not,
and thus to reduce the economic burden for health care systems and to improve health outcome for the patients.
GALAXY has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 668031
To give you the best possible experience, this site uses cookies Read more about cookies
Accept cookies